Drug information provided by: Merative, Micromedex®
Midostaurin is used in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy to treat newly diagnosed acute myeloid leukemia (AML) in patients who are FLT3 mutation-positive. Your doctor will perform a test to check for this mutation before you use this medicine.
This medicine is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia (MCL).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: Sept. 01, 2023